08.05.25 -- Tech Transfer 2025 – A High-Stakes Game Of Trust

Ensure a smooth and efficient technology transfer by following key strategies to streamline your process and achieve consistent, error-free results.

Discover how one family's race against time led to the creation of a groundbreaking gene therapy for their daughter, just 14 months after her ultra-rare disease diagnosis.

Without contract manufacturers, small biotechs often don't stand a chance of reaching commercial production scales, let alone global access for their drugs.

Lipid nanoparticles have revolutionized drug delivery, ushering in a new era. Observe how advanced analytical tools are accelerating the development of next-generation LNP therapeutics.

Developing a client-sponsored Target Product Profile (TPP) and Analytical Target Profile (ATP) is critical to move your drug product to clinic efficiently and meet acceptance criteria.

Review a study conducted to assess the effect of three commercially available cGMP-grade media and their influence on T-cell phenotype.

Uncover why this area is poised to become a leading hub for cell and gene therapy, as highlighted by CCS and industry experts at the 6th Annual Supply Chain Summit.

Examine a sponsor’s commitment to rigorous impurity control throughout manufacturing, as it is vital to ensuring continuous patient safety. 

Witness how our expertise plays a pivotal role in developing genetically engineered pharmaceuticals, which can propel your innovative therapies forward and transform patient care.

Cell and gene therapies offer transformative potential for treating complex diseases, but their manufacturing and global delivery face significant challenges.

Guarantee your business stays ahead in today’s complex regulatory environment by implementing robust affairs strategies that streamline compliance and product approvals.

Establish safety with expert-led viral clearance studies. Our global team delivers regulatory-compliant, scientifically robust solutions to eliminate viral risks and support the success of your product.

Immunotherapy is an evolving and promising cancer treatment that works by stimulating the immune system. However, they are not fully representative of what is going on in vivo.

Accelerate your gene therapy pipeline with our cost-effective, high-quality lentiviral vectors, optimized for clinical and commercial success.

Delve into our focus on selecting the correct buffer and excipient combinations, conducting thorough stability testing, and confirming device compatibility and dosing procedures.

Our deep expertise in cell line development, process optimization, and scalable GMP manufacturing ensures high-yield, high-quality protein production tailored to your therapeutic goals.